Best Topoisomerase Inhibitor for prostatic neoplasms
2 Topoisomerase Inhibitor drugs indicated for prostatic neoplasms, ranked by our independent rating. The current highest-rated is etoposide. Compare them with all treatments for prostatic neoplasms or the full Topoisomerase Inhibitor class. Not medical advice — always consult a professional.
Top topoisomerase inhibitor for prostatic neoplasms: 1. Etoposide · 2. Avopef
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Etoposide | Not yet rated | Prescription | — | View → |
| 2 | Avopef | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best topoisomerase inhibitor for prostatic neoplasms?
- By our independent rating, etoposide currently ranks highest among Topoisomerase Inhibitor drugs used for prostatic neoplasms. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which topoisomerase inhibitor drugs treat prostatic neoplasms?
- pharmaranks lists 2 Topoisomerase Inhibitor products indicated for prostatic neoplasms, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.